check quantity

IntegriSense 680 Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications. 

Please enter valid quantity

Please login to add favorites


Product Number List Price Your Price Quantity
NEV10645 663.00 USD

You successfully added item(s) to your cart


Integrins are transmembrane cell surface receptors which mediate signal transduction, cell-to-cell interaction and cell-to extracellular matrix adhesion, key processes involved in angiogenesis, tumorigenesis and metastasis. Integrins have thus been hailed as clinically-relevant biomarkers of pathological conditions such as inflammation and tumor progression. The integrin avb3 is significantly upregulated in tumor cells and activated endothelial cells during neoangiogenesis. 

IntegriSense™ 680 fluorescent imaging agent is used for in vivo detection of avb3 using a low molecular weight peptidomimetic antagonist coupled to a red fluorochrome. IntegriSense 680, an integrin-targeted molecular imaging agent allows the non-invasive imaging of disease status and progression. Pairing of an integrin antagonist treatment with IntegriSense 680 provides a mechanistic biomarker approach for assessing target coverage.

Disclaimer: For laboratory use only. This product is intended for animal research only and not for use in humans.

Fluorescent Agent Type Targeted
One Unit Contains 10 doses
Optical Imaging Classification Fluorescence Imaging
Product Brand Name IntegriSense
Shipping Condition Ambient
Therapeutic Area Atherosclerosis, Oncology/Cancer, Angiogenesis
Unit Size 1 Vial (10 doses)
Wave Length 680 nm